Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

50

Revenue 2017

Levemir

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Levemir was produced by Novo Nordisk.

Novo Nordisk preps for speedy oral GLP-1 drug filing

Novo Nordisk preps for speedy oral GLP-1 drug filing

products. Long-acting insulin sales shrank 6% to 20.8bn krone overall, mainly due to a sharp decline in top-seller Levemir (insulin detemir) which fell 21%, although there was a

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity Xultophy’s performance helped prop up the insulin category as it copes with a slide in sales of top seller Levemir (insulin detemir), which shrank by almost a quarter to

Novo says real-world data backs its insulin switching

Novo says real-world data backs its insulin switching It showed that switching to Tresiba (insulin from another basal insulin - mainly Sanofi's Lantus (insulin glargine U100) or Novo's own Levemir (insulin detemir) brand - improved blood glucose control and

Lilly and Boehringer launch first Lantus clone Basaglar in US

Lilly and Boehringer launch first Lantus clone Basaglar in US Nordisk's Levemir (insulin detemir) and Tresiba (insulin degludec). ... The list price of Basaglar in the US is $316.85 for a pack of five autoinjector pens, which also undercuts Sanofi's Lantus follow-up Toujeo, as well as Levemir

Sanofi fires off another lawsuit against a Lantus biosimilar

Sanofi fires off another lawsuit against a Lantus biosimilar Lantus made more than $7bn in sales last year but is already showing the effects of competition from biosimilars and other branded basal insulin rivals such as Novo Nordisk's Levemir

1 2 3 4 5 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics